Aberrant NOTCH1 signaling is implicated in the progression of various cancer types including breast cancer, leukemias, HNSCC and squamous cancers of the skin, esophagus, cervix, and lung [10,11,22,23,24,25,26]. This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.